The emergence of mutations encoding drug resistance is supposed to be a significant limitation to the clinical efficacy of inhibitor compounds directed against specific HIV-1 enzymatic targets. We have used a commercial test (Visible Genetics Inc., Paris, France) to study the prevalence of mutations
β¦ LIBER β¦
Evolution of HIV-1 in a patient population failing multiple-drug therapy
β Scribed by Shaolin Hong; Jingjiang Cao; Ya-ting Tu
- Book ID
- 108578348
- Publisher
- Center for Academic Publications, Japan
- Year
- 2009
- Tongue
- English
- Weight
- 222 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0385-5600
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Analysis of HIV-1 mutation patterns in p
β
Eugenia Quiros-Roldan; Simona Signorini; Francesco Castelli; Carlo Torti; Andrea
π
Article
π
2001
π
John Wiley and Sons
π
English
β 27 KB
π 2 views
Profile of drug resistance mutations amo
β
A. Jlizi; A. Ben Ammar El Gaaied; A. Slim; F. Tebourski; M. Ben Mamou; T. Ben Ch
π
Article
π
2008
π
Springer Vienna
π
English
β 239 KB
Recombination favors the evolution of dr
β
Antonio Carvajal-RodrΓguez; Keith A. Crandall; David Posada
π
Article
π
2007
π
Elsevier Science
π
English
β 568 KB
We studied the relationship between recombination and the fixation time of multiple drug resistance mutations after HIV-1 drug therapy, under a set of different realistic scenarios. We have generalized a previous model by Bretscher et al. [Bretscher, Althaus, Muller, Bonhoeffer, 2004. Recombination
High frequency of antiviral drug resista
β
Vivian KourΓ; Yoan AlemΓ‘n; Lissette PΓ©rez; Jorge PΓ©rez; Carlos Fonseca; Consuelo
π
Article
π
2012
π
Elsevier Science
π
English
β 639 KB
Antiretroviral drug resistance and viral
β
Pauskar, Merit; Huik, Kristi; Avi, Radko; Kallas, Eveli; JΓ΅geda, Ene-Ly; Karki,
π
Article
π
2014
π
BioMed Central
π
English
β 72 KB
HIV-1 genotypic resistance profile of pa
β
Toledo, Paula Virginia Michelon; de Carvalho, Denise Siqueira; Romagnoli, Luiza;
π
Article
π
2010
π
SciELO
π
English
β 959 KB